Sunwin ( SUWN ) explodiert !

Mr. Zhang further stated, "Obesity is at epidemic proportions, with the largest increase in young children. Stevia use by diabetics as well as health conscious individuals in the US has been growing substantially over the last 15 years. More and more parents are becoming aware of shopping for food products and supplements with reduced sugar levels. The average Stevia user spends $80 on product per year."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important, innovative, high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz

Safe Harbor Statement

Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contact:
Market Solutions, LLC
Tel: (561) 487-3674
Fax: (561) 237-2925
Email: info@sunwin.biz

Media/Analyst Contact:
Alan Stone & Company LLC
Alan Stone
212-521-4102
astone@alanstone.com


Quelle

Sunwin has developed a series of veterinary disinfectants employing traditional Chinese herbal medicine devised to combat the avian flu virus. The new line of disinfectants has been proven effective in inhibiting the spread of the H5N1 and H9N2 strands of the avian flu. The new series of veterinary disinfectants meets national sanitary standards established by the central government. Recently, Sunwin announced that the department of Livestock and Farming for Shandong Province Government has submitted a fast-track application to the Livestock Farming Bureau of China Ministry of Agriculture on behalf of Sunwin International Neutraceuticals, Inc.

Laiwang Zhang, President and Chairman of Sunwin International Neutraceuticals, Inc., stated, "The central government is mobilizing to prepare for a potential avian flu pandemic. Following the wave of reported cases of avian flu in China, we hope to witness strong demand for our products. Sunwin is committed to providing a solution to combat the avian flu."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit www.sunwin.biz

Safe Harbor Statement

Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contact:

Christina Hanneman
Tel:  303-220-8476
Fax:  303-773-6492
Email:  chrishanneman@mho.com

WSR REPORT
Sunwin International Neutraceuticals, Inc.  

www.wallstreetresearch.org/reports/suwn.htm

The Company sells stevioside on a wholesale basis to domestic food manufacturers and large foreign trade companies, which export the products to Japan, South Korea, as well as other countries in Southeast Asia and to a lesser extent globally. Stevioside is sanctioned by the Ministry of Health of China for use as a food additive and listed in the Sanitation Standard of Food Additives (GB2760). Similarly, stevia products are allowed to be sold as a food ingredient in much of Asia, including Japan, South Korea, Taiwan, Malaysia and Indonesia, parts of South America, such as Brazil and Paraguay, some Eastern European countries and Switzerland, as well as Israel and South Africa. However, some major global markets, including the U.S., the European Union (EU) and Australia, where stevioside is permitted only as a dietary supplement, remain largely inaccessible to producers of stevia-based sweeteners. In the U.S., without a GRAS (Generally Recognized As Safe) designation from the Federal Drug Administration (FDA), stevia use is limited to the confines of the Dietary Supplement and Health Education Act. As such, stevioside products are labeled, marketed and sold as dietary supplements, mostly in form of teas and shakes, but sometimes also as stand-alone extracts, which can effectively serve as sweeteners. The U.S. retail market for stevia products, which are primarily distributed through major health food stores like GNC and Whole Foods Market, although growing quickly, is currently estimated at only $20 million. The Company recently entered into an exclusive distribution agreement for its sweetener extract with United States Distribution Corp., which has strong relationships with 55,000 retail outlets across the U.S., including warehouses, mass retailers, grocery stores, pharmacies, restaurants, hotels, casinos, convention centers, stadium concessions, gas stations, convenience stores, and natural food chain stores. With superior taste than synthetic sweeteners and no known side effects, stevia products should eventually successfully compete within the $25 billion sweetener market in the U.S., as well as other industrialized markets currently dominated by aspartame-based products such as NutraSweet® or Equal®.

Nachtschwärmer IborCity